• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORDIS CASHEL SABER RX4MM10CM155; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORDIS CASHEL SABER RX4MM10CM155; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) CATHETER Back to Search Results
Model Number N/A
Device Problem Material Integrity Problem (2978)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 05/24/2019
Event Type  malfunction  
Manufacturer Narrative
The device was not returned for analysis.A device history record review was performed and showed that these lots of products met all requirements per the applicable manufacturing quality plan.Additional information is pending and will be submitted within 30 days upon receipt.
 
Event Description
A 4mm10cm155 saber rx percutaneous transluminal angioplasty (pta) catheter ruptured within nominal pressure after it crossed the lesion on an unspecified guidewire.The balloon catheter was replaced with 4x40 saber rx which was inflated three times and the procedure was continued.There was no patient injury.The device was discarded in the hospital.The target lesion was a chronic total occlusion (cto) in the popliteal artery.
 
Manufacturer Narrative
A 4mm x 10cm 155cm saber rx percutaneous transluminal angioplasty (pta) catheter ruptured within nominal pressure after it crossed the lesion on an unspecified guidewire.The target lesion was a chronic total occlusion (cto) in the popliteal artery.There was no patient injury.The balloon catheter was replaced with 4x40 saber rx which was inflated three times and the procedure was continued.The product was not returned for analysis.A product history record (phr) review of lot 17661797 revealed no anomalies or non-conformances during the manufacturing and inspection processes that can be associated with the reported event.The reported ¿balloon burst-at/below rbp¿ could not be confirmed as the device was not returned for analysis.The exact cause could not be determined.Vessel characteristics of a chronic total occlusion may have contributed to the reported event.According to the warnings in the safety information in the instructions for use ¿prior to angioplasty, the catheter should be examined to verify functionality and integrity, and ensure that its size and shape are suitable for the specific procedure for which it is to be used.Do not use if product damage is suspected or evident.To reduce the potential for vessel damage or the risk of dislodgement of particles it is very important that the inflated diameter of the balloon should approximate the diameter of the vessel just proximal and distal to the lesion.The balloon dimensions are printed on the product label.The compliance table incorporated with the product shows how balloon diameter increases as pressure increases.Do not exceed the rated burst pressure recommended on the label.The rated burst pressure is based on the results of in vitro testing.At least 99.9% of the balloons (with a 95% confidence) will not burst at or below their rated burst pressure.Use of a pressure monitoring device is recommended to prevent over-pressurization.Pressure in excess of the rated burst pressure can cause balloon rupture and potential inability to withdraw the catheter through the introducer sheath.Balloon rupture can cause vessel damage and the need for additional intervention.Use only the recommended balloon inflation medium (a 50/50 mixture by volume of contrast medium and normal saline).Never use air or any gaseous medium to inflate the balloon.¿ neither the phr nor the limited information available suggests a design or manufacturing related cause for the reported event; therefore, no corrective/preventive action will be taken at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SABER RX4MM10CM155
Type of Device
PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) CATHETER
Manufacturer (Section D)
CORDIS CASHEL
cahir road
co. tipperary
cashel
EI 
MDR Report Key8707267
MDR Text Key148301277
Report Number9616099-2019-03024
Device Sequence Number1
Product Code LIT
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Type of Report Initial,Followup
Report Date 07/12/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/18/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/31/2020
Device Model NumberN/A
Device Catalogue Number51004010L
Device Lot Number17661797
Was Device Available for Evaluation? No
Date Manufacturer Received07/10/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-